Cleared Traditional

K120679 - SYNAPSE 3D NODULE ANALYSIS

K120679 is the FDA 510(k) clearance for SYNAPSE 3D NODULE ANALYSIS by Fujifilm Medical Systems U.S.A, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K120679 · Fujifilm Medical Systems U.S.A, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
87d
Days
Class 2
Risk

K120679 is an FDA 510(k) clearance for the SYNAPSE 3D NODULE ANALYSIS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical Systems U.S.A, Inc. (Stamford, US). The FDA issued a Cleared decision on June 1, 2012 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical Systems U.S.A, Inc. devices

Submission Details

510(k) Number K120679 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2012
Decision Date June 01, 2012
Days to Decision 87 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 107d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1127
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K120679.
SYNGO.MR NEUROLOGY
K121459 · Siemens Medical Solutions USA, Inc. · Jun 2012
SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS
K120648 · Fujifilm Medical System U.S.A., Inc. · Jun 2012
SCENIUM 2.0
K121074 · Siemens Medical Solutions USA, Inc. · Jun 2012
QLAB WITH FHN AND VPQ PLUG-IN
K121223 · Philips Ultrasound, Inc. · May 2012
SYNAPSE 3D BRAIN PERFUSION
K120637 · Fujifilm Medical System U.S.A., Inc. · May 2012
SURGICASE CONNECT
K113599 · Materialise NV · Apr 2012